ABSTRACT. We measured concentrations of HaemophiProtection against invasive Hib infection correlates with the lus influenzae type b (Hib) polysaccharide antigen by presence of serum anticapsular antibody (1, 2). Antigens that ELISA in urine samples from 81 healthy North American stimulate production of anticapsular antibody come from a children with positive or negative throat cultures for Hib, variety of sources (3) (4) (5) . Important among these is asymptomatic to investigate the possibility that asymptomatic carriers nasopharyngeal colonization with Hib, which occurs in an estimay have antigenuria. For comparison, we determined the mated 38% of children before 5 y of age (5). Most children concentrations of Hib polysaccharide antigen in urine sam-colonized with Hib (carriers) who are 2 y of age and older develop ples from 56 patients with proven Haemophilus disease, high concentrations of serum anticapsular antibody (6-9). The including 13 children with lower respiratory infections who manner in which colonization results in increases in serum resided in developing countries. Among the healthy chil-anticapsular antibody concentration is not known (8, 10) but, dren, antigen was detected in the urine of seven of 19 (37%) because the children are asymptomatic, it has been presumed carriers of Hib compared with one of 62 (2%) children that the immunization occurs primarily via the mucosal route.
patients with invasive Haemophilus infections, 93% had asymptomatic carriers have evidence of antigenuria or invasive antigen detected. Although there was overlap in the con-Hib infection, which, if present, would be sources of systemic centrations of antigen in the positive urines from the immunization. asymptomatic carriers and those of the ill patients, the
In our study, we used a highly sensitive and quantitative ELISA concentrations of the ill patients were higher than those of to measure concentrations of type b polysaccharide in the urines the carriers. The respective geometric means of the positive of healthy nasopharyngeal camers of Hib. The concentrations of patients were: American patients with meningitis, 42.5 ng/ antigen in the urines of the camers were compared to the antigen mL (range 1.7-9800 ng/mL); American patients with in-concentrations in urine samples from healthy children with fections not involving the CNS, 5.8 ng/mL (range: 1.0-96 negative throat cultures, and from patients with proven inng/mL); patients from developing countries with lower vasive Hib diseases treated in the United States or in developing respiratory infections, 29.6 ng/mL (range: 0.9-5290), and countries. American asymptomatic carriers, 1.9 ng/mL (range: 0.6-16.7 ng/mL). Thus, antigenuria is present in a high proportion of healthy children with positive throat cultures for
MATERIALS AND METHODS

Hib, and the antigen concentrations of the carriers overlap
Healthy subjects, A signed consent for obtaining a throat those of ill ~atients. These results suggest that either culture and urine specimen was obtained from the parents of mucosal colonization itself is sufficient to produce antigen-preschool children attending five day care centers (n = 2), Colombia (n = 2), Guatemala (n = I), Papua New Guinea (n = 7), or Uruguay (n = I). Eight of the 13 isolates from these children were confirmed as serotype b in St. Louis. The remaining five isolates were not available for further study but four of the five were considered to be type b by the local laboratory. The fifth isolate was considered to be nontypable by the local laboratory but the child is included because type b polysaccharide was detected in the urine by ELISA. Throat cultures. Throat cultures were obtained from the healthy control children by thoroughly swabbing both tonsils and the posterior pharynx. The swab was placed in Brain Heart Infusion broth supplemented with Levinthal base and bacitracin, modifying the method previously described (12) . The broth was incubated overnight at 37°C in 5% COz and, the next day, an aliquot of 0.001 mL of the broth culture was inoculated onto chocolate agar medium and incubated overnight in the same manner. Colonies with typical morphology on chocolate agar were isolated for identification and confirmation of H. influenzae as described (1 I). The presence of the type b capsule was determined by precipitin halo formation on Levinthal agar containing 5% burro anti-H. influenzae type b antiserum (12) (Burro 132, serum generously provided by John Robbins, National Institutes of Health, Bethesda, MD).
Urine samples. Voided urine samples from the healthy children were collected by their parents or by day care personnel. The samples were refrigerated for up to 24 h before storing at -20 or -70°C. In the ill patients from Dallas and St. Louis, unused portions of urine samples that had been requested by the patients' physicians as part of the admission diagnostic evaluation were stored frozen at -20°C and assayed for antigen in batch as described below. In the patients from developing countries, the urine samples were obtained within 24 h of obtaining the blood cultures, and were transported and stored frozen until being assayed in St. Louis. Before testing, all urine samples were centrifuged for 1 min in an Eppendorf microfuge (model 54 12) to remove debris and cold precipitates. Urine samples from the asymptomatic children and ill patients were assayed without knowledge of the results of the throat cultures or the diagnosis, respectively.
Polysaccharide antigens. Capsular polysaccharides from Hib [strain Minn A, (13)], and Escherichia coli KlOO [strain Easter (3)] were purified from supernatants of stationary phase broth cultures, as previously described (14) . Protein (<2%) and nucleic acid (<I%) contents were determined as described (14) . Preparations of purified polysaccharide of Streptococcus pneumoniae types 3, 6, 14, 19, and 23 were obtained from the American Type Tissue Collection (Rockville, MD).
Antisera. To "capture" the polysaccharide antigen, we used affinity-purified anticapsular antibody purified from Hib burro antiserum. (This burro antiserum was provided by Dr. Mary Glode, University of Colorado School of Medicine, Denver, CO). Affinity purified anticapsular antibody was prepared on a Hib PS-aminohexy-sepharose column as previously described (1 5), and was stored frozen in small portions at a concentration of 1500 pg/mL of antibody, as determined by a radioantigen binding assay (14) . To detect the "captured" antigen, we used hyperimmune rabbit antisera as our second antibody. This antiserum was prepared at Washington University by immunization of a rabbit with repeated injections of H. influenzae b-diphtheria toxoid conjugate vaccine (Connaught Laboratories, Swiftwater, PA). Postimmunization sera were pooled and stored frozen in small portions. The anticapsular antibody concentration of the rabbit antiserum pool was approximately 700 pg/mL.
ELISA. The technique used was modified after that described by Pepple et al. (16) . The most important change was that we used affinity purified burro anticapsular antibody to capture Hib PS antigen, and used high-titer conjugate vaccine-induced rabbit antibody to detect complexed antigen, instead of using burro and rabbit antisera prepared against whole Hib bacterial cells as in the earlier study. Inasmuch as antisera to whole cells also contain antibodies to lipopolysaccharide and outer membrane proteins, this modification resulted in increased specificity of detection of capsular antigen. In brief, 96-well Limbro E.I.A. microtitration plates (Flow Laboratories, Inc., McLean, VA) were sensitized with 100 pL of affinity-purified burro anticapsular antibody, diluted to a concentration of 3 pg/mL of antibody in borate-buffered saline (pH 8.20) . After 4 h incubation at room temperature (-23"C), the plates were washed three times with PBS containing 0.05% Tween 20 (PBS-Tween, pH 7.40), and incubated for 1 h at room temperature with 100 pL of PBS containing 1 % BSA (blocking step). After washing three times with PBS-Tween, 100 pL of the urine samples was added to each well. The plates were incubated for 2 h at 37°C and then overnight at 4°C. The next day, the plates were washed three times with washing buffer and incubated at 37°C for 2 h with the rabbit anti-Hib PS antiserum, diluted 1:500 in PBS-Tween. The plates were then washed three times and the presence of the rabbit IgG was detected by incubation for 2 h at 37°C with alkaline phosphatase conjugated goat antirabbit IgG [whole molecule, affinity-isolated antibodies, absorbed by the manufacturer to remove reactivity to human serum proteins (Sigma no. A-7539, Sigma Chemical Company, St. Louis, MO)], followed by washing three times and adding a solution of p-nitrophenol phosphate (1 mg/mL) in 10% diethanolamine buffer (pH 9.8). Absorbance at 405 nm was monitored after 15, 30, and 45 min incubation using a Titertek multiscan spectrophotometer (Flow Laboratories). Negative controls on each ELISA plate consisted of duplicate wells containing normal human urine alone, and normal human urine with 5 pg/mL of Hib PS added and subsequently developed with normal rabbit serum instead of the immune rabbit serum as the second antibody. Both of these controls gave A values <0.20. Positive controls on each microtiter plate consisted of wells containing normal human urine to which Hib PS had been added to final concentrations of 5 and 1.2 ng/mL. The A values of these positive wells corresponded closely to those of the standard titration curve performed on one of the microtiter plates (representative A values of 1.6 and 0.7, respectively). Figure 1 shows a typical titration curve of absorbance as a function of concentrations of different polysaccharides added to urine from a healthy adult. [Identical curves were obtained when the polysaccharides were added to PBS (data not shown)]. The data shown represent the actual A values, without subtraction of background absorbance measured in the normal urine without added antigen. For detection of Hib PS, the assay was linear for sample dilutions of Hib PS producing A values of 0.3 to 1.5. Hib PS antigen concentrations 20.6 ng/mL gave absorbance values >3-fold above background and were considered positive. The urine from the healthy adult without added antigen, or the normal urine containing up to 10 000 ng/mL of pneumococcal polysaccharide types 3, 6, 14, 19, or 23 gave background absorbance values of <0.2. However, cross-reactive E. coli KlOO polysaccharide, containing a ribose (1-2) ribitol linkage instead of the ribose (1-1) ribitol linkage present in Hib PS, could be detected at concentrations of approximately 100-fold higher than that giving a positive reaction with Hib PS (Fig. 1) .
All urine samples from patients and healthy controls were initially assayed undiluted and positive results were confirmed in a second assay at which time a complete titration curve of the test sample was constructed by plotting absorbance as a function of reciprocal sample dilution, using a semilogarithmic scale. For urine samples with >5.0 ng/mL of Hib PS, concentrations of antigen were calculated from the sample dilution yielding an A value of 0.7 (i.e. the 0.7 intercept). In all instances, the titration curves of the test samples were parallel to that of the standard curve obtained with normal urine to which known concentrations of Hib PS had been added.
Comparison of ELISA with commercial agglutination tests.
In two blinded comparisons performed on normal urine to which different concentrations of Hib PS had been added, antigen concentrations between 0.6 and 1.2 ng/mL gave strong positive reactions by ELISA (A 20.6) but gave negative or inconclusive results when tested with three commercial agglutination tests, each performed according to the manufacturers' directions (Directigen, BBL Microbiologic Systems, Cockeysville, MD; Wellcogen, Wellcome Diagnostics, Dartford, England; and Bactigen, Wampole Laboratories, Cranbury, NJ). With the Directigen and Wellcogen tests, the lowest concentration of Hib PS to give a definite positive result was 5.0 ng/mL of antigen, and with the Bactigen, 2.5 ng/mL. The normal urine, to which antigen had not been added, gave negative results with the ELISA and with all three agglutination methods. Comparisons also were performed with dilutions of urine from a patient with Hib bacteremia: in this specimen, the ELISA was 4-to 6-fold more sensitive for antigen detection than any of the three commercial agglutination tests (data not shown).
Statistical methods. Log transformations were performed on the antigen concentrations of the urine samples, and the geometric means of the antigen concentrations of the carriers and the different patient groups were compared using a t test. In this analysis, only patients with detectable urine antigen were included. Other statistical comparisons were performed using a x2 test or Fisher exact test, when appropriate. Figure 2 shows the Hib polysaccharide antigen concentrations in urine samples from individual patients with Haemophilus disease and asymptomatic control children. Overall, 93% of the ill patients had antigen detected in urine (92% of the patients with LRI from developing countries, and 96 and 90%, respectively, of the patients from the United States with meningitis or other forms of invasive Hib disease). Among patients with positive urines, the geometric mean of the antigen concentrations of the patients with LRI from developing countries was not significantly different from that of the patients with meningitis from the United States (29.6 versus 42.5 ng/mL, respectively, p > 0.40). However, both of these patient groups had significantly higher urine antigen concentrations than those of the United States patients with invasive forms of Hib disease not involving the central nervous system (geometric mean = 5.2 ng/mL, p < 0.05).
RESULTS
Antigen was assayed by ELISA in coded urine samples from 81 healthy control children. A positive test was obtained in urines from seven of 19 (37%) of the healthy nasopharyngeal caniers compared with one of 62 (2%) of the children with negative throat cultures for Hib (odds ratio = 24.6, p = 0.0002). All eight positive samples from the healthy children gave A values well above that of the A value of the normal adult urine which served as a negative control. For example, the individual ratios of the A values in the positive specimens to that of the negative control urine ranged from 3.6 to >10 (median = 6.2). In contrast, the mean k SD of the corresponding ratios of the 73 test samples considered negative was 1 .OO 5 0.36. Thus, all eight of the samples considered positive from the healthy children had ratios >5 SD above that of the mean of the 73 test samples considered negative. There was overlap between the antigen concentrations in the urine samples from the seven healthy Hib carriers with positive urines and those of the ill patients. However, the geometric mean of the urine antigen concentrations of the seven carriers with positive urines (1.9 ng/mL) was significantly lower than that of V LRI, Dev. Nations A Meningitis, U.S.
Patients
Carriers Non-Carriers ng/mL, p < 0.04), or that of the positive patients with meningitis from the United States (42.5 ng/mL, p < 0.001). The geometric mean urine antigen concentration of the carriers also was lower than that of the urine-positive United States patients with Hib infections not involving the CNS but the difference was not significant (5.2 ng/mL, p = 0.08).
The urine samples from the healthy camers also were tested for the presence of Hib PS antigen using two of the commercial particle agglutination tests, Bactigen and Wellcogen. The Bactigen test gave 4+ and 3+ reactions in urines from two of the 19 carriers (1 1%). The two positive samples were those with the greatest concentrations of antigen as determined by ELISA (1 6.7 and 2.6 ng/mL). The Wellcogen test gave a positive reaction in one of the 19 samples (the urine with 16.7 ng/mL of antigen).
The one child with a negative throat culture for Hib and a positive urine by ELISA had 2.2 ng/mL of antigen detected. This infant was 5 mo of age and had been afebrile for more than 30 d before the collection of the urine and throat culture specimens. Of note, this patient's urine was also positive for Hib PS antigen by the Bactigen and Wellcogen agglutination tests (I+ to 2+, and 1 +, respectively).
DISCUSSION
The ELISA used in our study was highly sensitive for detection of Hib PS. In general, this assay also was quite specific but, as shown in Figure 1 , the assay could detect some other polysaccharides, such as E. coli K100, which is chemically similar and known to cross-react with Hib PS. Therefore, although approximately one-third of the pharyngeal carriers of Hib studied had detectable antigenuria, we can not rigorously prove that the antigen present in their urine was Hib PS. However, this possibility seems compelling given that all but one of the healthy children with antigenuria had positive throat cultures for type b Haemophilus, and the fact that several of the caniers also had antigen detected in their urine by commercial Hib agglutination tests.
False-positive tests for Hib antigen can be caused by a number of factors, including specimen contamination or actual infection with cross-reacting bacteria (17, 18) . In our study, urine cultures were not obtained, so we cannot rule out the possibility that the antigenuria in some of the children may have been the result of specimen contamination by cross-reacting bacteria such as E. coli KlOO (Fig. 1) . However, we consider this possibility unlikely since only one of 62 control children with negative throat cultures for Hib had antigen detected in urine.
During Hib bacteremic infection, type b polysaccharide can be detected in the circulation and in the urine. In previous studies, the presence of Hib antigen in the urine of ill patients has been considered presumptive evidence of invasive Hib infection (19, 20) . An exception is children recently vaccinated with Hib polysaccharide in whom Hib polysaccharide can be excreted in the urine for periods of 1 to 10 days (21). Our finding of antigenuria in some carriers suggests that Hib colonization without clinical evidence of invasive infection also is sufficient to produce antigenuria. The mechanism is unclear. It is possible that some caniers experience transient Hib bacteremia. Alternatively, antigenuria could result from local bacterial invasion of the mucosal tissues and release of antigen into the circulation. Less likely is the possibility that Hib polysaccharide is swallowed and absorbed directly from the gastrointestinal tract, eventually reaching the circulation and urine.
Previously, we have shown that most Hib camers >2 y of age develop high concentrations of serum anticapsular antibody (7, 9) . Inasmuch as the children in these studies were generally asymptomatic, we considered it likely that the serum antibody response to Hib colonization was a result of mucosal immunization, i.e. local antigenic stimulation of lymphocytes residing in the nasopharynx with subsequent clonal expansion and trafficking of plasma cells into the circulation and secretion of serum antibody. However, our finding of antigenuria in some children colonized with Hib suggests that systemic immunization from circulating capsular antigen might-be important and possibly necessarv for the develo~ment of serum anticavsular antibodies in healthy caniers. In their studies of infant rats colonized with Hib, Gilsdorf and Ferrieri (22) reached similar conclusions. They found that colonization alone was insufficient to evoke serum bactericidal activity against Hib, and that bacteremia appeared to be necessary (22) . Note, however, that infant rats infected with Hib show low serum anticapsular antibody responses, and the bactericidal antibodies that develop appear to be directed against noncapsular antigens (23) .
In summary, our data indicate that a high proportion of asymptomatic children who are camers of Hib have detectable antigenuria. Questions that remain to be studied include the relationship between time of acquisition of carriage and appearance of antigen in the urine, details of the pathophysiology, and the relative roles of mucosal antigenic stimulation versus systemic antigenemia in eliciting serum anticapsular antibody responses in Hib carriers.
